May 20, 2020 / 04:30PM GMT
Unidentified Analyst -
Good afternoon, and thank you for coming to the 2020 Virtual UBS Global Healthcare Conference. My name is [Ang Lee], and I'm happy to be your host for this session. Our next presenter will be Mr. Nick Colangelo, President and Chief Executive Officer of Vericel. (Operator Instructions)
We will now turn it over to Mr. Nick Colangelo. Thank you.
Dominick C. Colangelo - Vericel Corporation - CEO, President & Director
Well, thank you. It's a pleasure to be here today. And before I begin, I would just like to remind you that this presentation contains forward-looking statements and you should refer to our documents on file with the SEC for further information.
I understand that these slides are viewer-driven, so I will prompt you as I'm moving forward through the presentation. So beginning on Slide 3, Vericel is a leader in advanced therapies for the sports medicine and severe burn care markets. We have a highly innovative advanced cell therapy platform that we acquired in 2014 from Sanofi, and we're currently marketing 2 advanced
Vericel Corp at UBS Global Healthcare Conference (Virtual) Transcript
May 20, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers